Henry Schein, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Henry Schein, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Cash Cushion Ratio: Debt, after subtracting cash, equals 34% of its market value (net debt). Lower than 90% of Healthcare companies in United States.
- Tangible Net Worth Ratio: Goodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative. Less tangible than 89% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
$171Over the last 3 years, every $100 of reported profit came with $171 of operating cash.
Higher than 64% of Healthcare companies in United States.
Self-Funding Ratio
3.6×Over the last 3 years its own operating cash covered its investment spending (capex) 3.6 times.
Higher than 81% of Healthcare companies in United States.
Cash Locked Ratio
$18For every $100 of sales, $18 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $18 tied up three years earlier.
Less money tied up than 63% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
2/3 · 1/3Sales grew in 2 of the last 3 years; profit grew in 1 of 3.
Steadier than 50% of Healthcare companies in United States.
Growth Efficiency Ratio
—Sales barely changed
Sales changed by +4% in 3 years, too little to measure extra profit per extra sales.
Asset Productivity Ratio
+4% / +30%In 3 years sales changed by +4% while total assets changed by +30%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
0.9×Debt due within a year is covered 0.9 times by its yearly operating cash.
Higher than 72% of Healthcare companies in United States.
Cash Cushion Ratio
−34%Debt, after subtracting cash, equals 34% of its market value (net debt).
Lower than 90% of Healthcare companies in United States.
Tangible Assets Ratio
53%Of every $100 the company owns, $53 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 76% of Healthcare companies in United States.
Tangible Net Worth Ratio
NegativeGoodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative.
Less tangible than 89% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Henry Schein, Inc. owes $0.58 for every $1 it owns. Net profit rose 2% in the year to Dec 2025, and shrank 10% a year on average over 3 years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
25.1Investors pay $25.1 for every $1 of Henry Schein, Inc.'s yearly profit, lower than 54% of Healthcare companies in United States.
P/B ratio
3.04The share price is 3.04 times Henry Schein, Inc.'s book value per share, higher than 56% of Healthcare companies in United States.
Market cap
$9.6 BThe total market value of all of Henry Schein, Inc.'s shares at today's price (share price × number of shares), larger than 89% of Healthcare companies in United States. PosiCap size class: Meso Cap.
Net worth (book value)
$3.2 BWhat Henry Schein, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$28.33Net worth divided by the number of shares. The share price of $86.00 is 3.0 times this, which is the P/B above.
Return on equity (ROE)
8.9%Henry Schein, Inc. earned 8.9% on its shareholders' money over the last year, higher than 82% of Healthcare companies in United States.
Owes vs Owns
0.58×Henry Schein, Inc. owes $0.58 for every $1 it owns (moderate), higher than 63% of Healthcare companies in United States.
Dividend yield
NoneHenry Schein, Inc. does not currently pay a dividend.
Revenue growth
+4%Revenue rose 4% in the year to Dec 2025, and grew 1% a year on average over 3 years.
Profit growth
+2%Net profit rose 2% in the year to Dec 2025, and shrank 10% a year on average over 3 years.
Profit margin
3.0%Henry Schein, Inc. keeps $3 of every $100 of revenue as net profit.
Cash quality
1.8×Cash from Henry Schein, Inc.'s business was 1.8× its reported profit in the year to Dec 2025 — its profit turned into cash.
Interest cover
5.1×Henry Schein, Inc.'s operating profit covered its interest costs 5.1 times in the year to Dec 2025.
Cash vs debt
Net debtHenry Schein, Inc. had $3.3 B more debt than cash (net debt) at Dec 2025.
Questions
What is Henry Schein, Inc.'s P/E ratio?
Investors pay $25.1 for every $1 of Henry Schein, Inc.'s yearly profit, lower than 54% of Healthcare companies in United States.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Henry Schein, Inc.: $9.6 B ÷ $3.2 B (30 Jun 2026) = 3.0.
What is Henry Schein, Inc.'s return on equity?
Henry Schein, Inc. earned 8.9% on its shareholders' money over the last year, higher than 82% of Healthcare companies in United States.
How much does Henry Schein, Inc. owe compared with what it owns?
Henry Schein, Inc. owes $0.58 for every $1 it owns (moderate), higher than 63% of Healthcare companies in United States.
Does Henry Schein, Inc. pay a dividend?
No. Henry Schein, Inc. does not currently pay a dividend.
Is Henry Schein, Inc.'s revenue growing?
Revenue rose 4% in the year to Dec 2025, and grew 1% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.